![]() |
市場調查報告書
商品編碼
1562278
2030 年亞太地區門診中央履行市場預測 - 區域分析 - 按產品類型和最終用戶Asia Pacific Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type and End User |
2022年亞太地區門診中央履行市價為5,060萬美元,預計2030年將達到1.2644億美元;預計2022年至2030年複合年成長率為12.1%。
不斷成長的老齡化人口和新興市場推動亞太地區門診中央履行市場
人口老化是醫療保健產業進步的關鍵。因此,預計不斷成長的老齡化人口將為藥房提供重要的成長機會。根據聯合國《2022年世界人口展望》報告,老年人口預計將從2022年佔總人口的10%增加到2050年佔總人口的16%。成長未來幾年的護理和藥物。全球預期壽命的激增也導致需要更多數位化和自動化的成人照護系統。自動配藥機的發展為已開發地區帶來了效益。 LED 顯示器、馬達控制器和警報系統等先進功能可協助人們進行用藥提醒。自動化藥房系統將使他們能夠更好地追蹤藥品和庫存。此外,實施自動化藥局系統引發了成人用藥依從性。憑藉這些功能,自動化藥局系統的採用預計在未來幾年將在日本、印度、韓國和中國等發展中國家成長。
由於醫療保健成本不斷上升以及改善藥物服務可近性的壓力,藥品管理在發展中國家至關重要。為了方便取得藥品,發展中國家政府正在採取各種策略。由於慢性病盛行率激增、醫院擴大採用最新醫療技術以及對先進醫療技術的認知不斷增強,大多數市場參與者都將注意力集中在中國、印度和阿拉伯聯合大公國等新興市場。
亞太地區門診中央履行市場概覽
中國是亞太地區最大的門診集中履行市場。中國的「十三五」規劃將健康和創新放在首位,增加了對先進醫療設備的需求。此外,老年人口的增加和慢性病的增加也促進了該國門診中心履行市場的發展。熟練勞動力的供應、低廉的營運成本和巨大的生產空間進一步吸引了市場領導者在中國設立生產工廠。中國與其他國家醫療保健系統的差異導致了中國醫療事故的區域特徵。因此,該國的自動化藥品配藥顯著增加,特別是在 COVID-19 大流行期間。 2021年,湖南長沙醫院率先安裝機器人發藥系統,加強藥品發藥。自動化技術也廣泛應用於醫療保健領域,利用了對自動化藥局系統的需求。中國是向西方國家最大的活性藥物成分出口國,需要對運輸產品的包裝和標籤進行自動化。生產基地和倉庫在生產基地安裝了自動化藥局系統。
中國的許多新創公司都致力於開發配藥技術。例如,COBOT 是一家開發和銷售工業機器人智慧系統的新創公司。它開發了下一代智慧配藥機器人並將其商業化。它還可以透過藥品管理系統自動補充庫存。
亞太地區門診中央履行市場收入及 2030 年預測(百萬美元)
亞太地區門診中央履行市場區隔
亞太地區門診中央履行市場依據產品類型、最終用戶和國家進行細分。根據產品類型,亞太地區門診中央履行市場分為自動配藥系統、自動包裝和標籤系統、自動桌面櫃檯、自動儲存和檢索系統等。 2022 年,自動配藥系統領域佔據最大的市場佔有率。
就最終用戶而言,亞太地區門診中央履行市場分為醫院藥局、零售藥局和郵購藥局。 2022年,醫院藥局領域佔據最大的市場佔有率。
依國家/地區分類,亞太地區門診中央履行市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022 年,中國在亞太地區門診集中履行市場佔有率中佔據主導地位。
貝克頓·迪金森公司;卡普薩解決方案有限責任公司;康德樂 (Cardinal Health) 公司、麥克森公司 (McKesson Corp);和 Omnicell Inc 是亞太地區門診中心履行市場的一些領先參與者。
The Asia Pacific outpatient central fulfillment market was valued at US$ 50.60 million in 2022 and is expected to reach US$ 126.44 million by 2030; it is estimated to record a CAGR of 12.1% from 2022 to 2030.
Rising Aging Population and Emerging Markets Boosts Asia Pacific Outpatient Central Fulfillment Market
The aging population is a key to advancements in the healthcare sector. Thus, the growing aging population is anticipated to serve vital growth opportunity for the pharmacy. According to the United Nations World Population Prospects 2022 report, the elderly population is projected to increase from 10% of the total population in 2022 to 16% of the total population by 2050. The rapidly growing aging population indicates an exponential rise in demand for elderly care and medicines in the coming years. An upsurge in life expectancy worldwide has also led to the need for more digital and automated systems for adult care. The development of automatic medicine dispensers has served beneficially in developed regions. Advanced features such as an LED display, a motor controller, and an alarm system help people with medication reminders. Automated pharmacy systems would enable them to keep track of their medicine and stocks better. Further, implementing automated pharmacy systems has triggered adult medication adherence. With such features, the adoption of automated pharmacy systems is expected to grow in developing countries such as Japan, India, South Korea, and China in the coming years.
Pharmaceutical management is essential in developing countries owing to rising healthcare costs and pressure to improve access to pharmaceutical services. To ease access to drugs, governments of developing countries are adopting various strategies. Most market players focus on emerging markets such as China, India, and the UAE due to the surging prevalence of chronic diseases, rising adoption of the latest medical technologies in hospitals, and increasing awareness about advanced medical technologies.
Asia Pacific Outpatient Central Fulfillment Market Overview
China is the largest market for outpatient central fulfillment in Asia Pacific. The 13th Five-Year Plan of China that prioritized health and innovation has augmented demand for advanced medical devices. Moreover, the rising geriatric population and increasing chronic health conditions contribute to the outpatient central fulfillment market in this country. The availability of skilled laborers, low cost of operations, and massive space for production have further attracted the market leaders to have their production plants in China. Differences between the healthcare systems in China and other countries result in region-specific patterns of medical malpractice in China. Thus, the country has seen a significant rise in automated pharmaceutical dispensing, especially during the COVID-19 pandemic. In 2021, the Hospital of Changsha in the Hunan province was the first to install robotic pharmacy dispensing systems to enhance drug dispensing. Automation technologies are also widely used in the healthcare sector, leveraging demand for automated pharmacy systems. China is the largest exporter of active pharmaceutical ingredients to Western countries, requiring automation for the packaging and labeling of the products to be shipped. Production sites and warehouses have automated pharmacy systems installed in the manufacturing site.
Many startups in China are engaged in developing technologies for dispensing medicines. For instance, COBOT is a startup company that develops and markets smart systems for industrial robots. It has developed and commercialized a next-generation, smart medicine-dispensing robot. It can also automatically replenish stocks through a drug management system.
Asia Pacific Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Outpatient Central Fulfillment Market Segmentation
The Asia Pacific outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the Asia Pacific outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.
In terms of end user, the Asia Pacific outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
Based on country, the Asia Pacific outpatient central fulfillment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific outpatient central fulfillment market share in 2022.
Becton Dickinson and Co; Capsa Solutions, LLC; Cardinal Health Inc, McKesson Corp; and Omnicell Inc are some of the leading players operating in the Asia Pacific outpatient central fulfillment market.